Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
NATI.US
id: 710
National Instruments (NATI) M&A Case
On April 12, 2023, Emerson (NYSE: EMR) and National Instruments (Nasdaq: NATI) announced that they entered into a definitive agreement under which Emerson will acquire NI for $60 per share in cash at an equity value of $8.2 billion.
Emerson already owned approximately 2.3 million shares of NI, representing approximately 2% of shares outstanding, which were acquired at a weighted average price of $36.84.
Investors of $NATI may have reasons to suspect that the pricing terms of the M&A transaction are unfair and that the Company BoD breached fiduciary duties to shareholders.
Case Status
Attorney Investigation
Alleged Offence
Misleading Statements,
Financial Misrepresentation,
Failure to Disclose,
Malpractice,
Breach of Fiduciary duty,
Omissions
Suspected Party
Directors,
Management,
Shareholder,
Investment Bank,
Service Provider
Security Type
Stocks
Trade Direction
Long
Shock Event Date
12 April 2023